Background Children who are identified through population screening to have multiple islet
autoantibodies (stage 1) type 1 diabetes are at increased risk for progressing to clinical type …

OBJECTIVE Children identified with stage 1 type 1 diabetes are at high risk for progressing
to stage 3 (clinical) diabetes and require accurate monitoring. Our aim was to establish …

Context Accurate measures are needed for the prediction and diagnosis of type 1 diabetes
(T1D) in at-risk persons. Objective The purpose of this study was to explore the value of …

Aims To evaluate the feasibility of CGM use in prediction of diabetes in children with
incidental hyperglycemia (IH) and negative diabetes-related autoantibodies. Methods Thirty …

OBJECTIVE We explore continuous glucose monitoring (CGM) as a new approach to
defining early hyperglycemia and diagnosing type 1 diabetes in children with positive islet …

Objective To assess whether introduction of continuous glucose monitoring (CGM) at
diagnosis of type 1 diabetes (T1D), leads to greater uptake and continuation at 12 and 24 …

Background: Children with positive islet autoantibodies monitored prospectively avoid
metabolic decompensation at type 1 diabetes (T1D) diagnosis. However, the effects of early …

Objective. To further evaluate glycemic outcomes during the observational extension phase
of the Continuous Glucose Monitoring (CGM) Intervention for Teens and Young Adults …

Objective: To describe sociodemographic and parent psychosocial characteristics
associated with patterns of continuous glucose monitor (CGM) use across the first 18 months …

Aims/hypothesis We aimed to determine whether disease severity was reduced at onset of
clinical (stage 3) type 1 diabetes in children previously diagnosed with presymptomatic type …